Alnylam reports positive Phase II immunoglobulin A nephropathy data
In the trial, cemdisiran offered a 37% mean decline from baseline in the 24-hour urine protein to creatinine ratio versus…

In the trial, cemdisiran offered a 37% mean decline from baseline in the 24-hour urine protein to creatinine ratio versus…
The Clinical Trials Arena team also dig into benign tumours, hepatitis B, lymphomas, myelofibrosis, polycythemia vera, and soft tissue sarcoma.
ByIn the trial, single and multiple doses of TQS-168 demonstrated to be well tolerated in 78 healthy subjects.
The double-blind, placebo-controlled, randomised trial will analyse ATH434 in subjects with early-stage MSA.
The trial will analyse the safety and efficacy of BIIB122 in nearly 640 Parkinson’s patients aged between 30 and 80…
The GBM AGILE trial is currently underway at 44 clinical centres in the US and Canada.
If approved, zavegepant will be the first and only intranasal treatment for migraine in the gepant drug class.
ByClario’s eCOA Multimedia technology will be merged with clinical network and expertise of Cogstate in neurodegenerative ailments.
Thank you for subscribing to Clinical Trials Arena